drugset / Trial / NCT06616571
Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this real-world study is to compare the efficacy and safety of QL0605 administered 24 hours and 48 hours after chemotherapy in breast cancer patients.
Timeline
- Start
- 2024-09-19
- Primary completion
- 2025-12-30
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pegfilgrastim | Protein / enzyme biologic | — | Subcutaneous |